Упрощенная HTML-версия
164
42. Hofmeyr GJ, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing
hypertensive disorders and related problems. Cochrane Database Syst Rev
2006;3:CD001059.
43. Makrides M,Crowther CA. Magnesium supplementation in pregnancy. Cochrane Database
Syst Rev 2001;CD000937.
44. Han L, Zhou SM. Selenium supplement in the prevention of pregnancy induced hypertension.
Chin Med J (Engl) 1994;107:870-1.
45. Ziaei S, Hantoshzadeh S, Rezasoltani P, Lamyian M. The effect of garlic tablet on plasma
lipids and platelet aggregation in nulliparous pregnants at high risk of preeclampsia. Eur J
Obstet Gynecol Reprod Biol 2001;99:201-6.
46. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with
antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev
2005;CD002859.
47. 190. Walker MC, Ferguson SE, Allen VM. Heparin for pregnant women with acquired or
inherited thrombophilias. Cochrane Database Syst Rev 2003;CD003580.
48. Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, et al. Low-molecular-weight
heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular
changes in angiotensin-converting enzyme DD women. Hypertension 2005;45:86-91.
49. Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy
outcomes: a population-based study. Lancet 2006;368:1164-70.
50. Meher S, Duley L. Exercise or other physical activity for preventing pre-eclampsia and its
complications. Cochrane Database Syst Rev 2006;CD005942.
51. Mozurkewich EL, Luke B, Avni M, Wolf FM. Working conditions and adverse pregnancy
outcome: a meta-analysis. Obstet Gynecol 2000;95:623-35.
52. Meher S, Duley L. Rest during pregnancy for preventing pre-eclampsia and its complications
in women with normal blood pressure. CochraneDatabase Syst Rev 2006;CD005939.
53. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, et al. Effect of antioxidants on the
occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet
1999;354:810-6.
54. Beazley D, Ahokas R, Livingston J, Griggs M, Sibai BM. Vitamin C and E supplementation in
women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet
Gynecol 2005;192:520-1.
55. Rumiris D, Purwosunu Y, Wibowo N, Farina A, Sekizawa A. Lower rate of preeclampsia after
antioxidant supplementation in pregnant women with low antioxidant status. Hypertens
Pregnancy 2006;25:241-53.
56. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamin C and vitamin E in pregnant
women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet
2006;367:1145-54.
57. International Trial of Antioxidants for the Prevention of Preeclampsia [website]. The INTAPP
trial
of
vitamins
C
and
E
before
18
weeks.
Available
at:
http://www.obstgyn.ca/mfmresearch/INTAPP. Accessed January 22, 2008.
58. Churchill D, Beevers G, Meher S, Rhodes C. Diuretics for preventing pre-eclampsia. Cochrane
Database Syst Rev 2007;CD004451.
59. Lumley J, Oliver SS, Chamberlain C, Oakley L. Interventions for promoting smoking cessation
during pregnancy. Cochrane Database Syst Rev 2004;CD001055.
60. The management of severe pre-eclampsia and eclampsia. Royal College of Obstetricians and
Gynaecologists (RCOG). Guideline #10(A), March, 2006.
61. Diagnosis and management of pre-eclampsia and eclampsia. American College of
Obstetrician and Gynecologists (ACOG). Practice Bulletin #33, 2002. Obstet.Gynecol, 2002;
99: 159-167.
62. Why mothers die 1997-1999. The confidential enquiries into maternal deaths in the UK.
London: RCOG Press;2001.
63. Martin JN Jr, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe
preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet
Gynecol 2005;105:246-54.
64. Brown MA, Mangos G, Davis G, Homer C. The natural history of white coat hypertension
during pregnancy. BJOG 2005;112:601-6.